Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: July 20, 2018

DrugPatentWatch Database Preview

Novast Labs Company Profile

« Back to Dashboard

What is the competitive landscape for NOVAST LABS, and what generic and branded alternatives to NOVAST LABS drugs are available?

NOVAST LABS has thirty-four approved drugs.

There are three tentative approvals on NOVAST LABS drugs.

Summary for Novast Labs

US Patents:	0
Tradenames:	33
Ingredients:	20
NDAs:	34

Drugs and US Patents for Novast Labs

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Novast Labs Ltd	CLOBETASOL PROPIONATE (EMOLLIENT)	clobetasol propionate	CREAM;TOPICAL	075733-001	Aug 22, 2001		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Novast Labs Ltd	HER STYLE	levonorgestrel	TABLET;ORAL	207976-001	Mar 11, 2016		OTC	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Novast Labs Ltd	CARISOPRODOL AND ASPIRIN	aspirin; carisoprodol	TABLET;ORAL	040832-001	Jan 7, 2010	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Novast Labs Ltd	LARIN 24 FE	ethinyl estradiol; norethindrone acetate	TABLET;ORAL	202994-001	Feb 18, 2015	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS

Queensland Health

Teva

Daiichi Sankyo

Deloitte

AstraZeneca

Johnson and Johnson

McKinsey

Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.